At the Exploring DNA Repair Pathways as Targets for Cancer Therapy conference, we presented findings on harnessing liquid biopsy to detect DDR biomarkers in CTCs.
Latest report
Interim Report June 2024
Please click the links below to download our Annual and Interim Reports and Financial Statements
Open PDFFor any investor relations queries please contact
investor@angleplc.comFor any investor relations queries please contact
investor@angleplc.comAt the Exploring DNA Repair Pathways as Targets for Cancer Therapy conference, we presented findings on harnessing liquid biopsy to detect DDR biomarkers in CTCs.